Human Uterine Lavage: First Live Births from In Vivo Conceived Genetically Screened Blastocysts.


Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
05 2023
Historique:
received: 08 02 2023
accepted: 24 02 2023
medline: 17 5 2023
pubmed: 30 3 2023
entrez: 29 3 2023
Statut: ppublish

Résumé

We wish to report the first live births from genetically screened human euploid blastocysts obtained by uterine lavage. The embryos transferred to infertile women were previously obtained using a novel fully automated uterine lavage catheter and fluid recovery device developed for this indication. The objective of this portion of the research was to confirm embryo implantation and live births with these unique in vivo conceived blastocysts obtained by uterine lavage. In vivo conceived embryos recovered by uterine lavage 5 days after intrauterine insemination were available for embryo donation. In vivo embryos were the result of prior controlled ovarian stimulation cycles in oocyte donors and intrauterine insemination with donor sperm. An observational case series of nine embryo transfer procedures was performed at an outpatient fertility center. One to two embryos were transferred to eight infertile women since one woman had two separate embryo transfer procedures. Nine embryo transfer procedures were performed with 14 blastocysts in eight women resulting in a blastocyst implantation rate of 36% (5/14) and live birth rate of 44% (4/9). Five infants have been born from the four delivered pregnancies with one set of twins. This is the first report of live births from genetically screened human euploid blastocysts obtained by uterine lavage. The nonsurgical uterine lavage office procedure represents the only current approach to obtain in vivo conceived embryos and can provide a benchmark for comparison to standard in vitro cultured blastocysts. Live births of in vivo conceived blastocysts represent the validation that the nonsurgical uterine lavage procedure allows simplified access to naturally conceived embryos without performing the surgical procedure of an oocyte aspiration. Owing to its simplicity, uterine lavage may be useful in screening embryos for preimplantation genetic testing for aneuploidy in fertile and infertile couples. ClinicalTrials.gov (Identifier NCT03426007). The overall goal of this research was to develop a procedure that would allow collection of naturally conceived human embryos and compare them to embryos that result from the standard process of in vitro fertilization (IVF). IVF is a procedure where eggs are surgically removed from the ovaries and fertilized with sperm in a laboratory. Embryos from IVF are cultured for 3–7 days before they are placed back into a woman’s uterus to establish a pregnancy. Uterine lavage is a different procedure where the sperm fertilizes an egg in the normal process of conception and the uterus is rinsed with fluid to recover the embryo before implantation. The embryos reported in this study were the first to be obtained in over 30 years owing to many improvements in the overall uterine lavage procedure. Until our initial study findings reported in 2020, the vast majority of information on embryo development was based on embryos fertilized and cultured in a laboratory. Our prior report of embryos obtained by uterine lavage compared with IVF embryos from the same women demonstrated a significantly better appearance of the embryos recovered by lavage. This current report documents the first live births from these genetically screened naturally conceived human embryos. The live births provide evidence that uterine lavage allows ready access to normal embryos without performing the surgical procedure IVF. Owing to the simplicity of uterine lavage, the procedure may improve access to genetic testing of embryos before pregnancy.

Autres résumés

Type: plain-language-summary (eng)
The overall goal of this research was to develop a procedure that would allow collection of naturally conceived human embryos and compare them to embryos that result from the standard process of in vitro fertilization (IVF). IVF is a procedure where eggs are surgically removed from the ovaries and fertilized with sperm in a laboratory. Embryos from IVF are cultured for 3–7 days before they are placed back into a woman’s uterus to establish a pregnancy. Uterine lavage is a different procedure where the sperm fertilizes an egg in the normal process of conception and the uterus is rinsed with fluid to recover the embryo before implantation. The embryos reported in this study were the first to be obtained in over 30 years owing to many improvements in the overall uterine lavage procedure. Until our initial study findings reported in 2020, the vast majority of information on embryo development was based on embryos fertilized and cultured in a laboratory. Our prior report of embryos obtained by uterine lavage compared with IVF embryos from the same women demonstrated a significantly better appearance of the embryos recovered by lavage. This current report documents the first live births from these genetically screened naturally conceived human embryos. The live births provide evidence that uterine lavage allows ready access to normal embryos without performing the surgical procedure IVF. Owing to the simplicity of uterine lavage, the procedure may improve access to genetic testing of embryos before pregnancy.

Identifiants

pubmed: 36988819
doi: 10.1007/s12325-023-02486-1
pii: 10.1007/s12325-023-02486-1
doi:

Banques de données

ClinicalTrials.gov
['NCT03426007']

Types de publication

Journal Article Observational Study

Langues

eng

Pagination

2534-2541

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Healthcare Ltd., part of Springer Nature.

Références

Munné S, Nakajima ST, Najmabadi S, et al. First PGT-A using in vivo blastocysts recovered by uterine lavage: comparison with matched IVF embryo controls. Hum Reprod. 2020;35:70–80.
doi: 10.1093/humrep/dez242 pubmed: 31886877
Munné S, Nakajima ST, Najmabadi S, et al. Corrigendum. First PGT-A using in vivo blastocysts recovered by uterine lavage: comparison with matched IVF embryo controls. Hum Reprod. 2021;36:2069–70.
doi: 10.1093/humrep/deab097 pubmed: 33904920 pmcid: 8213447
Munné S, Blazek J, Large M, et al. Detailed investigation into the cytogenetic constitution and pregnancy outcome of replacing mosaic blastocysts detected with the use of high-resolution next-generation sequencing. Fertil Steril. 2017;108:62–71.
doi: 10.1016/j.fertnstert.2017.05.002 pubmed: 28579407
Gardner DK, Lane M, Stevens J, et al. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73:1155–8.
doi: 10.1016/S0015-0282(00)00518-5 pubmed: 10856474
Buster JE, Bustillo M, Rodi IA, et al. Biologic and morphologic development of donated human ova recovered by nonsurgical uterine lavage. Am J Obstet Gynecol. 1985;153:211–7.
doi: 10.1016/0002-9378(85)90116-4 pubmed: 4037016
Pennings G. Uterine lavage: ethics of research and clinical applications. Hum Reprod. 2020;35:1949–53.
doi: 10.1093/humrep/deaa140 pubmed: 32649750
De Santis L, Cimadomo D, Capalbo A, et al. IUI and uterine lavage of in vivo-produced blastocysts for PGT purposes: is it a technically and ethically reasonable perspective? Is it actually needed? J Assist Reprod Gent. 2020;37:1579–82.
doi: 10.1007/s10815-020-01813-7
Nakajima ST, Najmabadi S, Rivas JL, et al. Fertility and sterility dialog. In vivo lavage (IVL): clinical uses and a new option for fertility preservation, 2020 September. https://www.fertstertdialog.com/posts/in-vivo-lavage-ivl-clinical-uses-and-a-new-option-for-fertility-preservation . Accessed July 1, 2022.

Auteurs

Sam Najmabadi (S)

Center for Reproductive Health and Gynecology, 99 N. La Cienega Blvd., Suite 109, Beverly Hills, CA, 90211, USA.

José L Rivas (JL)

Punta Mita Fertility Center/Center for Reproductive Health and Gynecology, Punta Mita Hospital, Ramal Carretera Federal 200 KM 19 No. 1, C.P. 63734, Punta de Mita, Nayarit, Mexico.

Marlane J Angle (MJ)

Laurel Fertility Care, 1700 California St., San Francisco, CA, 94109, USA.

Alexander Nadal (A)

Previvo Genetics, Inc, 10233 South Parker Road, Suite 300, Parker, CO, 80134, USA.

Ercan Bastu (E)

Department of Gynecology and Obstetrics, Acibadem University School of Medicine, Besiktas, Istanbul, Turkey.

Santiago Munné (S)

Overture Life, Avenida de Europa 4, Alcobendas, 28108, Madrid, Spain.
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, 310 Cedar Street, RM 337, New Haven, CT, 06510, USA.

Sandra A Carson (SA)

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, 310 Cedar Street, RM 337, New Haven, CT, 06510, USA.

John E Buster (JE)

Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, 101 Dudley St., Providence, RI, 02905, USA.

Steven T Nakajima (ST)

Department of Obstetrics and Gynecology, Stanford University School of Medicine, 1195 West Fremont Ave., Suite 1301, Sunnyvale, CA, 94087, USA. stevenn@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH